MHRA says EU rules are unclear on software in medical devices

04/10/2013 | Clinica (subscription required)

The U.K. Medicines and Healthcare Products Regulatory Agency announced plans to work with the European Commission to clarify how proposed rules for medical devices and in vitro diagnostics affect software. The agency also plans to work with other EU stakeholders on defining "companion diagnostics" and "near patient-testing," and on supply chain responsibilities. Stakeholders told the agency that the proposed rules lack clarity, and many objected to proposed rules allowing some reprocessing of single-use devices.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ